University Hospital of Ferrol
Welcome,         Profile    Billing    Logout  
 9 Trials 
3 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
López, Manuel Carlos
NCT03006965: Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT®

Completed
N/A
50
Europe
octocog alfa, Advate®, recombinant intravenous factor VIII, rurioctocog alfa pegol
Spanish Society of Thrombosis and Haemostasis, Takeda, Instituto de Investigación Hospital Universitario La Paz
Hemophilia A, Hemophilia, Factor VIII Deficiency
12/22
12/22
Rodríguez, José Manuel Ramírez
MATINEE, NCT04133909 / 2018-001540-56: Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

Jan 2024 - Dec 2024: Acceptance of regulatory submission in US (based on MATINEE trial) for COPD
Jan 2024 - Dec 2024: Acceptance of regulatory submission in EU (based on MATINEE trial) for COPD
Jan 2024 - Dec 2024: Data from MATINEE trial for COPD
Jan 2024 - Dec 2024: Acceptance of regulatory submission in China (based on MATINEE trial) for COPD
Hourglass Jul 2024 - Dec 2024 : Regulatory decision in Japan for COPD
Completed
3
806
Europe, Canada, US, RoW
Placebo, Mepolizumab
GlaxoSmithKline, PPD DEVELOPMENT, LP
Pulmonary Disease, Chronic Obstructive
08/24
08/24
NCT05757102: A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

Recruiting
3
292
US, RoW
FF/UMEC/VI, ELLIPTA, FF/VI
GlaxoSmithKline
Asthma
01/27
01/27
Pérez, Manuel Llácer
No trials found

Download Options